NCT05493020

Brief Summary

The purpose of this study is to record the "Mukbang" watching behavior and appetite of children with cancer during inpatient radiotherapy and chemotherapy through intensive longitudinal study, explore their correlation, and the impact on their nutritional status and quality of life, and formulate for clinical departments relevant interventions and management options provide a theoretical basis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
179

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 9, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

November 24, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

July 27, 2022

Last Update Submit

April 13, 2026

Conditions

Keywords

MukbangChildhood cancerAppetiteMalnutritionQuality of LifeIntensive Longitudinal Study

Outcome Measures

Primary Outcomes (2)

  • Appetite

    The appetite will be assessed by Cancer Appetite and Symptom Questionnaire(CASQ) . The questionnaire consisted of 12 items, each item ranged from 0 to 4 points, and the total score of the questionnaire ranged from 0 to 48 points. The lower the total score, the worse the patient's appetite.

    Appetite change over 5 days during chemoradiotherapy from baseline

  • Mukbang Watching Features

    The "Mukbang" watching features will be assessed by a questionnaire designed by the researcher and recorded by the subjects themselves, including watching time, watching rate, watching preferences and watching experience.

    Mukbang Watching Features change over 5 days during chemoradiotherapy from baseline

Secondary Outcomes (2)

  • Nutritional status

    Change in nutritional status over 7 days from baseline

  • Quality of Life in children with cancer

    Change in quality of life over 7 days from baseline

Study Arms (1)

Questionnaires assessed children with cancer

Children with cancer who received at least one radiotherapy and chemotherapy during hospitalization

Other: Questionnaires set

Interventions

At baseline, the children's demographics, disease-related data, characteristics of "Mukbang"watching behavior, appetite, nutritional status, and quality of life data were collected. From the first day of radiotherapy or chemotherapy, 3 meals a day for 5 consecutive days were followed to track the children's appetite status and the characteristics of "Mukbang"watching behavior. Their nutritional status and quality of life were tracked at the end of treatment or when they were discharged from the hospital.

Questionnaires assessed children with cancer

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

178 children with cancer who have received at least one radiotherapy or chemotherapy during hospitalization

You may qualify if:

  • Aged 3-18;
  • Children who conform to the Notice on Printing and Distributing the Diagnosis and Treatment Specifications for 12 Diseases Related to Hematological Diseases and Malignancies in Children (2021 Edition) issued by the General Office of the National Health and Health Commission;
  • Experienced at least one complete cycle of chemotherapy and radiotherapy.

You may not qualify if:

  • Children with severe cardiopulmonary disease, severe infection, severe organ damage, genetic metabolic disease, immunodeficiency disease or mental illness;
  • Children with eye and ear dysfunction at the same time, resulting in the inability to watch and listen to videos.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

XIAW

Guangzhou, Guangdong, 510080, China

Location

MeSH Terms

Conditions

NeoplasmsMalnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Wei Xia

    Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 27, 2022

First Posted

August 9, 2022

Study Start

November 24, 2022

Primary Completion

June 30, 2023

Study Completion

December 30, 2023

Last Updated

April 16, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations